AI-Powered High-Content Screening for Complex 3D Assays
Unlock Deeper Insights from Advanced 3D Models
Traditional imaging methods often struggle to capture the complexity of physiologically relevant 3D assays. Discover how next-generation high-content screening combined with AI-driven analysis enables researchers to generate faster, more accurate, and reproducible insights from patient-derived organoid models.
The ImageXpress® HCS.ai High-Content Screening System delivers exceptional imaging performance and intelligent analysis capabilities designed specifically for complex 3D workflows.
Key Benefits
- Achieve over 4.5x improvement in signal-to-noise ratio in thick 3D samples
- Capture high-resolution images faster with QuickID™ Targeted Acquisition
- Leverage AI-powered segmentation and phenotypic classification tools
- Quantify dose-dependent responses with enhanced accuracy
- Generate scalable, multiparametric data for advanced drug discovery workflows
Why Researchers Are Interested
This application note demonstrates how AI-enabled imaging and analysis can help improve the evaluation of patient-derived colorectal cancer organoids, enabling deeper phenotypic insights while streamlining acquisition and analysis workflows.
Researchers used:
- Intelligent targeted acquisition workflows
- Deep Tissue Confocal Spinning Disk imaging
- AI-driven segmentation using SINAP
- Machine learning classification with Phenoglyphs™
The result is a faster, smarter, and more scalable approach to complex 3D assay analysis.
Download the Application Note
Learn how advanced imaging and AI-analysis tools are helping researchers improve 3D drug screening workflows and generate more meaningful biological insights.